AMR-Miami launches RSV (Respiratory Syncytial Virus) vaccine phase 3 clinical research; now enrolling volunteers ages 60+ at 14 AMR research centers across U.S.
RSV is a life-threatening, hidden epidemic for growing population of adults 60+ with over 177,000 hospitalizations — and 14,000 deaths — every year Highly contagious, RSV spreads like COVID-19 and exacerbates chronic medical...
Read More













